StockNews.com began coverage on shares of IGC Pharma (NYSEAMERICAN:IGC – Free Report) in a report issued on Wednesday morning. The brokerage issued a sell rating on the construction company’s stock.
IGC Pharma Price Performance
NYSEAMERICAN IGC opened at $0.44 on Wednesday. The company has a market capitalization of $29.33 million, a P/E ratio of -1.69 and a beta of 1.71. The company has a debt-to-equity ratio of 0.02, a quick ratio of 0.86 and a current ratio of 1.85. IGC Pharma has a 12 month low of $0.25 and a 12 month high of $0.91.
IGC Pharma (NYSEAMERICAN:IGC – Get Free Report) last released its quarterly earnings data on Wednesday, February 14th. The construction company reported ($0.09) EPS for the quarter. IGC Pharma had a negative net margin of 1,163.24% and a negative return on equity of 110.37%. The company had revenue of $0.20 million for the quarter.
Hedge Funds Weigh In On IGC Pharma
IGC Pharma Company Profile
IGC Pharma, Inc, a clinical stage biotechnology company, engages in developing cannabinoid-based formulations for treating diseases and conditions, including Alzheimer's disease, dysmenorrhea, premenstrual syndrome, and chronic pain. The company has two investigational drug assets targeting Alzheimer's disease comprising IGC-AD1, which is in a Phase 2B clinical trial as a treatment for agitation in dementia due to Alzheimer's; and TGR-63 that is in pre-clinical development.
Featured Articles
- Five stocks we like better than IGC Pharma
- Stock Analyst Ratings and Canadian Analyst Ratings
- High-Yield Texas Instruments Could Hit New Highs Soon
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Pagaya Technologies: An AI Fintech That Insiders Are Buying
- How to Read Stock Charts for Beginners
- Higher Oil Prices Could Give NextEra’s Stock Earnings a Boost
Receive News & Ratings for IGC Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IGC Pharma and related companies with MarketBeat.com's FREE daily email newsletter.